53 related articles for article (PubMed ID: 493780)
1. [Adaptation and dependence to morphine in severe painful syndromes (author's transl)].
Mazars G; Mérienne L
Rev Neurol (Paris); 1979 Feb; 135(2):177-82. PubMed ID: 493780
[No Abstract] [Full Text] [Related]
2. The physical dependence liabilities of oxybutynin and morphine in rats.
Algate DR; Beard DJ
Arzneimittelforschung; 1985; 35(10):1577-9. PubMed ID: 4074417
[TBL] [Abstract][Full Text] [Related]
3. [Endorphins: a key to understanding pain, addiction and mental disorders?].
Herz A
Dtsch Med Wochenschr; 1979 Mar; 104(11):371-3. PubMed ID: 421664
[No Abstract] [Full Text] [Related]
4. [Clinical study on the development of dependency after long-term treatment with tramadol (author's transl)].
Flohé L; Arend I; Cogal A; Richter W; Simon W
Arzneimittelforschung; 1978; 28(1a):213-7. PubMed ID: 343791
[No Abstract] [Full Text] [Related]
5. The short- and long-termed effects of beta-endorphin on the opiate abstinence syndrome in rats.
Haracz JL; Tseng LF
Commun Psychopharmacol; 1980; 4(3):219-24. PubMed ID: 6262008
[No Abstract] [Full Text] [Related]
6. Dopamine and 5-HT supersensitivity in nonorganic central pain and in morphine abstinence: fortuitous or renal analogy?
Sicuteri F; Anselmi B; Del Bianco PL
Adv Biochem Psychopharmacol; 1980; 22():523-33. PubMed ID: 7395606
[TBL] [Abstract][Full Text] [Related]
7. Enkephalin analogs and physical dependence.
Wei ET
J Pharmacol Exp Ther; 1981 Jan; 216(1):12-8. PubMed ID: 7192734
[TBL] [Abstract][Full Text] [Related]
8. Morphine dependence and self-stimulation: attenuation of withdrawal-induced weight loss.
Glick SD; Marsanico RG; Zimmerberg B; Charap AD
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):725-32. PubMed ID: 4735638
[No Abstract] [Full Text] [Related]
9. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
11. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
Windh RT; Little PJ; Kuhn CM
J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
[TBL] [Abstract][Full Text] [Related]
12. Time course of dependence and tolerance development in rats treated with "slow release" morphine suspensions.
Frederickson RC; Smits SE
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):867-70. PubMed ID: 4735639
[No Abstract] [Full Text] [Related]
13. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
Mamiya T; Matsumura T; Ukai M
Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
[TBL] [Abstract][Full Text] [Related]
14. [Differences in activity between substance P and substance P-heptapeptide as studied on the phenomenon of "gut dependence" in rats (author's transl)].
Nieber K; Oehme P
Pharmazie; 1982 May; 37(5):368-9. PubMed ID: 6180443
[TBL] [Abstract][Full Text] [Related]
15. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
Smits SE
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
Marshall I; Grahame-Smith DG
J Pharmacol Exp Ther; 1971 Dec; 179(3):634-41. PubMed ID: 4257807
[No Abstract] [Full Text] [Related]
18. Serotonin participation in gut withdrawal from opiates.
Gintzler AR
J Pharmacol Exp Ther; 1979 Oct; 211(1):7-12. PubMed ID: 573789
[No Abstract] [Full Text] [Related]
19. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Neal BS; Sparber SB
J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between dependence on and tolerance to morphine in the rat (author's transl)].
Fernandes M; Kluwe S
Arzneimittelforschung; 1976; 26(6):1100-2. PubMed ID: 989387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
